.
MergerLinks Header Logo

New Deal

New Deal

Announced

Cathay Fortune International failed to acquire Epigenomics.

Synopsis

Cathay Fortune International, an investment company, failed to acquire Epigenomics, a Germany-based molecular diagnostics company. Financial terms were not disclosed.

Principals

Epigenomics

target

Epigenomics

Cathay Fortune Corporation

bidder

Cathay Fortune Corporation

Show Details & Financials

Market Context

Sort

Yilong Du

Yilong Du

Latham & Watkins
Deal Bio
Total Deals
4/
Total Value
£10M
Dirk Kocher

Dirk Kocher

Partner at Latham & Watkins
Deal Bio
Total Deals
17/
Total Value
£9,303M
Harald Selzner

Harald Selzner

Partner at Latham & Watkins
Deal Bio
Total Deals
16/
Total Value
£4,411M
Qiuning (Frank) Sun

Qiuning (Frank) Sun

Partner at Latham & Watkins
Deal Bio
Total Deals
37/
Total Value
£8,264M

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required
Register nowSign up with LinkedIn

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US